Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia

JAAD Case Rep. 2020 Jan 22;6(2):122-123. doi: 10.1016/j.jdcr.2019.12.007. eCollection 2020 Feb.

Authors

Katarina T Nguyen¹, Courtney C Gwinn², Jay C Vary Jr²

Affiliations

¹ School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
² Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.

No abstract available

Keywords: AIHA, autoimmune hemolytic anemia; autoimmune hemolytic anemia; dermatitis herpetiformis; rituximab.

Publication types

Case Reports